Predictive biomarker for cancer therapy

• 收藏
• 分享

专利权人:

MOLOGEN AG

发明人:

MATTHIAS SCHROFF,MANUEL SCHMIDT,KERSTIN KAPP,BURGHARDT WITTIG

申请号：

GB201309657

公开号：

GB2514591A

申请日:

2013.05.30

申请国别(地区):

GB

年份:

2014

代理人:

摘要：

A method for predicting or monitoring whether a patient suffering from cancer or an auto immune disease will respond to treatment with a TLR-9 (toll-like recptor 9) agonist by determining the frequency of activated natural killer T (NKT) cells. The agonist may be a DNA construct comprising a sequence motif N1N2CGN3N4, wherin N1N2 and N3N4 is any combination of A, C, G and T. Also claimed is the use of a TLR-9 agonist to treat cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/